Astellas Pharma to acquire Iota Biosciences for bioelectronics technology

Astellas Pharma Inc. announced it will acquire Iota Biosciences, Inc., a start-up company with unique ultrasonic-powered bioelectronic devices technology. The acquisition is expected to accelerate Astellas' Rx+ business by acquiring innovative technology for ultra-small implantable medical devices.

“Through the acquisition of iota, Astellas will acquire iota's unique bioelectronics technology and world-class talent.”newsroom.astellas.com

• 1 source
• newsroom.astellas.comGlobal News | AstellasOct 15, 2020

Summarized from public sources; check the original articles before acting on it.